Fourteen large U.S. MJGs — pharma and tech — read from their latest 10-K income-tax notes, using the jurisdiction-level disclosures introduced by ASU 2023-09. For each group: the pre-tax profit split (U.S. vs foreign), income tax paid by jurisdiction, and revenue by geography.
Horizontal: the share of revenue earned in the U.S. Vertical: the share of pre-tax profit booked there. On the diagonal, the two match. Below zero, the U.S. operation reports a pre-tax loss.
Only MJGs where Ireland cleared the 5%-of-total disclosure threshold under ASU 2023-09 report a line. Six MJGs in the set disclose none — their Irish tax fell below the threshold. Apple is not yet covered by the standard.
Current provision for income taxes, U.S. (federal and state) against foreign, from each group’s income-tax note. Excludes the deferred provision and legacy repatriation instalments.
Pick a group to read its full 10-K income-tax picture — the pre-tax split, the provision (current and deferred), income tax paid by jurisdiction, and revenue by geography, with the note on what shapes the year.